Varian Medical Systems Inc

Varian Medical Systems — Presentation (November 2018)

15 slides from Varian Medical Systems's investor presentation, Nov 27, 2018

  1. Slide 1: Governance Update December 2018

    Governance Update December 2018

  2. Slide 2: Varian today – a snapshot

    Varian today – a snapshot A focused cancer company Global Leader in radiation therapy FY18 revenues $2.9B >8,000 medical linear accelerators >40 worldwide training centers software installs 5,000 proton therapy rooms 70 employees 7,000 Cancer patients touched/year >3M 2 Varian is a leader in the fig

  3. Slide 3: Long-term growth and value creation strategy

    Long - term growth and value creation strategy Global Leader in Radiation Therapy Radiation oncology OIS Radiosurgery Brachytherapy Radiation oncology treatment planning Proton therapy Radiation therapy Global Leader in Multi - Disciplinary, Integrated Cancer Care Solutions Interventional oncology S

  4. Slide 4: Strong financial growth in FY18

    Strong financial growth in FY18 Annual Revenues +11% $2,919 Million 1 GAAP to Non - GAAP reconciliation is disclosed in Varian’s fiscal year 2018 fourth quarter earnings press release and furnished to the Securities Exchange Commission (“SEC”) in a Form 8 - K on October 23, 2018 . GAAP EPS was reduc

  5. Slide 5: Record-setting fourth quarter and fiscal year 2018 regional orders

    • First $1B orders quarter, with $3B orders in the full fiscal year • Record APAC orders for the year with 31% orders growth in APAC in the 4 th quarter, the strongest quarter in APAC history • First $1B orders year in EMEA, in conjunction with 5 th consecutive quarter of double - digit orders growt

  6. Slide 6: Executing on long-term growth strategy

    Executing on long - term growth strategy • TrueBeam, ARIA, and Eclipse named 2018 Best in KLAS category leaders • Launched Halcyon 2.0 with kV CBCT imaging • Acquired Mobius Medical Systems and humediQ Key accomplishments – FY 2018 Strengthen Leadership in Radiation Therapy • Acquired leading local

  7. Slide 7: Commitment to corporate governance best practices

    Commitment to corporate governance best practices 7 Majority voting for election of directors Declassified board Separate CEO and independent Chair roles 5 new independent directors in last 5 years 4 women on board, 40% gender diversity Proxy access bylaw

  8. Slide 8: Varian's Board possesses deep and diverse expertise

    Varian’s Board possesses deep and diverse expertise 8 Powerful combined skillset, strongly aligned with the Company’s strategic objectives INDUSTRY KNOWLEDGE Contributes to a deeper understanding of healthcare trends and technologies and our business strategy, operations, key performance indicators

  9. Slide 9: 2018 CEO compensation program overview

    13% 11% 46% 30% 2018 CEO compensation program overview 9 1 Other NEOs receive long - term equity granted in PSUs (60%), RSUs (20%) and Stock Options (20%) 2 Economic profit is referred to internally as Varian Value Added (VVA); see slide 11 for details regarding how we calculate VV A Base Salary Att

  10. Slide 10: 2018 compensation program changes

    2018 compensation program changes We have made several changes to our executive compensation program to better align incentives with our growth strategy and best practices 10 Component 2017 Program 2018 Program Rationale for Change Annual Cash Incentive Management Incentive Plan ► EBIT Growth (50%)

  11. Slide 11: Varian Value Added (VVA)

    Varian Value Added (VVA) VVA is a measure of economic profit that drives long - term value creation 11 Varian Value Added ► VVA accommodates volatility by rewarding continuous improvement Growth in VVA reflects appropriate R&D investment that serves as the foundation for our future growth and long -

  12. Slide 12: Why VVA?

    Why VVA? The Compensation Committee selected VVA, an economic profit metric, as the core financial metric in our Annual Cash Incentive for several reasons: 12 Ownership culture Decision making Balance Value driver Motivates and encourages leaders to own their decisions and the results and consequenc

  13. Slide 13: How VVA encourages growth and ownership

    Appropriately Values New Assets to Encourage Growth Values R&D as an Investment for Long - Term Growth Encourages Ownership Mentality and Accountability ► Treats R&D as an investment rather than an expense ► Removes distortions that encourage underinvestment in R&D to meet short - term objectives at

  14. Slide 14: Sustainability at Varian

    Sustainability at Varian 14 Extending access to quality healthcare, delivering safe and effective products, and having a beneficial impact on the communities where we operate • Our efforts focus on: − Operational Excellence: growing our business while reducing our environmental impact, maintaining h

  15. Slide 15: Sustainability at Varian: Operational and innovation highlights

    Sustainability at Varian Operational and innovation highlights 15 1 Improves access to quality care for millions of patients globally 2 Half the weight of a traditional machine 3 Uses half the energy of a traditional machine 4 Requires two thirds less concrete and is self - shielding 5 Uses less SF

Varian Medical Systems — Presentation (November 2018) on 6ix